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A total of 860 serum samples collected at 86 cattle farms in different parts 
of Hungary were screened for the presence of antibodies to Mycoplasma bovis us-
ing an ELISA test with a recombinant M. bovis membrane protein as antigen. An-
tibodies to M. bovis were detected in sera collected on all farms, and no farms 
negative for M. bovis were found. In 88.38% of the herds more than 50% of the 
sampled animals were infected by M. bovis. A total of 82.91% of the animals had 
antibodies to M. bovis. The proportion of seropositive animals was higher in the 
older age groups, and a significant difference was seen in the level of seropositiv-
ity between young and older age groups. The results show that M. bovis infection 
is widespread on Hungarian dairy farms, and its prevalence has increased in the 
recent decade. The high infection rate of Hungarian cattle herds with M. bovis 
shows that special attention should be paid to evaluating the aetiological role of 
M. bovis in bovine respiratory disease complex (BRDC) cases because M. bovis has 
an immunosuppressive effect and can predispose cattle to other respiratory infec-
tions, too.  
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The bovine respiratory disease complex (BRDC) is one of the most impor-
tant diseases of cattle causing considerable losses all over the world, and My-
coplasma bovis is an important agent in its aetiology (Cusack et al., 2003; Nicho-
las and Ayling, 2003). It is responsible for a wide range of clinical diseases in-
cluding bronchopneumonia, arthritis, genital diseases, mastitis (Gagea et al., 
2006b; Arcangioli et al., 2008; Bürki et al., 2015), otitis (Arcangioli et al., 2012) 
and keratoconjunctivitis (Kirby and Nicholas, 1996). By replicating on the mu-
cous membranes of the respiratory tract and interacting with other pathogenic 
bacteria, it compromises the defence mechanism of the host and has a synergistic 
effect with the pathogenic activity of other bacteria (Gagea et al., 2006a). It is an 
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important agent of pneumonia at the beginning of the feeding period and in 
young dairy calves (Gagea et al., 2006a; Giovannini et al., 2013). According to 
Nicholas and Ayling (2003), M. bovis is responsible for one quarter to one third 
of the losses caused by bovine respiratory diseases. 
Several methods are used for the detection of M. bovis or the antibodies 
produced to it. Besides isolation of the agent, capture ELISA and different PCR 
methods are available (Tenk et al., 2002; Nicholas and Ayling, 2003; Tenk et al., 
2006). Antibodies to M. bovis can be detected with ELISA tests using whole cell 
or chemically treated antigens. To prevent cross-reactions with other mycoplas-
mas, different membrane proteins are frequently used as antigens in ELISA tests 
(Adamu et al., 2013; Fu et al., 2014). Some new ELISA tests can even differenti-
ate between vaccinated and naturally infected cattle (Han et al., 2015). The sero-
logical detection of M. bovis infection is regarded more reliable in the diagnostic 
work, since antibody levels remain high for many months and the presence of an-
tibodies indicates an invasive infection in contrast to nasal colonisation (Nicholas 
and Ayling, 2003). 
Mycoplasma bovis is widespread in the cattle population: it can be found 
on the mucous membranes of the respiratory and genital tracts as well as in the 
udder. This agent could be detected in 11.6% of lung tissue samples from dairy 
calves younger than one month (Giovannini et al., 2013), and antibodies to M. 
bovis were found in all veal calves and 76% of adult cattle at slaughter in Italy 
(Radaelli et al., 2008). Mycoplasma bovis could be found in 34.4% of nasal sam-
ples from three-month-old calves (Siugzdaite et al., 2012), while it was present 
in 53.3% of the respiratory samples of calves in 4 veal herds in Pennsylvania 
(Soehnlen et al., 2012). A high level of seropositivity (60–100%) to M. bovis was 
seen in the majority of veal calves in France, too (Arcangioli et al., 2008). On the 
other hand, M. bovis was detected in only 2% of the calves in backgrounding and 
stocker cattle operations in Georgia in the US (Wiggins et al., 2007), and no M. 
bovis positive sera could be found in 135 randomly selected Norwegian dairy 
herds (Gulliksen et al., 2009). Mycoplasma bovis had first been detected in Hun-
garian cattle herds several decades ago (Romváry et al., 1977), and its pathologic 
importance was confirmed later (Stipkovits et al., 2000; Bashiruddin et al., 2001; 
Tenk et al., 2004). The latter authors could detect antibodies to M. bovis in 11.3% 
of the animals tested; however the agent could be cultured from 37.0% of the 
animals. 
It is presumed that M. bovis as an immunosuppressive agent has an impor-
tant role in the pathogenesis of BRDC in Hungary but we do not know how 
widespread the infection is at present. A few years ago 34 large cattle herds were 
screened (Tenk et al., 2004), but the increased trade of recent years could have 
changed the figures. This perception is supported by the results of a recent phy-
logenetic examination of Hungarian M. bovis strains, which has confirmed the 
heterogeneity of the strains by detecting two clades and five subclades in one of 
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the clades (Sulyok et al., 2014). The aim of the present work was to obtain in-
formation on the current seroprevalence of M. bovis in cattle herds in Hungary in 
order to assess its possible role in BRDC. 
 
 
Materials and methods 
Blood samples were collected in 86 large cattle herds from different parts 
of Hungary between February and October 2008. The samples were collected 
during routine diagnostic examinations, thus an ethical approval was not required 
for the study. Altogether 82 dairy herds were included in the screening, together 
with one beef herd and three herds of mixed use. The size of the herds ranged be-
tween 216 and 2600 head of cattle. Ten blood samples were randomly collected 
in each herd from animals preferably older than three months; however, there 
were 26 samples which had been collected from calves younger than three 
months. The age of the animals ranged between 37 days and 7 years. The sam-
ples were transported to the laboratory in a cooler box within 4 h after collection, 
and the sera were separated and stored at –18 °C until tested. 
The Bio K 162 Bio-X Mycoplasma bovis ELISA Kit (Bio-X Diagnostics, 
Jemelle, Belgium) sensitised with a recombinant protein from M. bovis was used. 
The tests were carried out according to the manufacturer’s instructions. Briefly, 
100 μl each of the 1:100 diluted sera was put into two wells of the microtitration 
plate: one well was sensitised with M. bovis protein, while the other served as 
negative control. The plates were incubated at 37 °C for 1 h. After washing, the 
conjugate (a peroxidase-labelled anti-bovine IgG1 monoclonal antibody) was 
added to the wells and incubated at 37 °C for 1 h. The plates were washed, hy-
drogen peroxide substrate and tetramethylbenzidine chromogen were added and 
incubated at room temperature for 10 min, then the reaction was stopped. The in-
tensity of the blue colour was read at 450 nm using an ELISA reader (Multiskan 
EX, Labsystems, MTX Lab Systems Inc.). The test was validated using the posi-
tive serum provided by the manufacturer; it was regarded valid if the optical den-
sity of the positive serum exceeded the value stated by the producer. 
The test was evaluated according to the manufacturer’s instructions. To 
define the exact optical density (OD) value of the sample, the signal of the nega-
tive control well was subtracted from the measured value of the sample. This OD 
was compared with that of the positive serum and expressed as the percentage of 
the latter (sample coefficient, ODC%). The ODC% values were scored; below 
10.5% the test was considered negative, and the positive results were scored be-
tween + and +++++. The average ODC% of the sera of four age groups (< 3, 4–
6, 7–9, 10–12, > 12 months) were calculated using the Unscrambler 10.3 pro-
gramme (CAMO Software AS., Oslo, Norway) and evaluated by Student’s t-test. 
The statistical unit was the individual animal. 
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Results and discussion 
Antibodies to M. bovis were detected in all herds, no M. bovis free herds 
were found. In most herds (88.38%) more than 50% of the animals were sero-
positive to M. bovis (Table 1). 
Table 1 
Seropositivity of cattle herds to Mycoplasma bovis 
Number of positive 
samples out of 10 
collected in a herd 
Number of herds % of herds 
0 0 0 
1 0 0 
2 2 2.32 
3 1 1.16 
4 1 1.16 
5 6 6.98 
6 6 6.98 
7 9 10.47 
8 10 11.63 
9 17 19.77 
10 34 39.53 
 
Regarding the seropositivity of the individual animals, only 17.09% of the 
cattle were seronegative but most of the seropositive animals did not have high 
levels of antibodies (Table 2). The level of seropositivity tended to increase with 
age (Table 3). 
Table 2 
Seropositivity of individual cattle to Mycoplasma bovis 
Antibodies to M. bovis Number of animals % of animals 
Negative 147 17.09 
Positive + 525 61.05 
 ++ 132 15.35 
 +++ 42 4.88 
 ++++ 14 1.63 
 +++++ 0 0 
 Total 713 82.91 
Total 860 100 
 
Nowadays the aetiological role of M. bovis in BRDC is widely accepted, 
and there are more and more data on its occurrence in cattle herds in different 
countries. There are several diagnostic methods for evaluating the level of infec-
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tion in herds. Detection of antibodies to M. bovis is frequently used, as this test 
shows the infection for a longer time even if antibiotic treatment is performed, 
and it indicates not only carriage of M. bovis on mucous membranes but also in-
vasiveness (Nicholas and Ayling, 2003). When using serological tests, it is diffi-
cult to rule out false seropositivity caused by related antigens of other my-
coplasmas. The ELISA test applied in the present project is widely used; thanks 
to its recombinant M. bovis membrane protein antigen the reaction is considered 
specific (Gulliksen et al., 2009; Gabinaitiene et al., 2011; Arcangioli et al., 2012; 
Fu et al., 2014). Examination of the sera using further ELISA tests or paired 
samples could refine the results but our aim was only to obtain information on the 
current seroprevalence of M. bovis in order to assess its possible role in BRDC. 
Table 3 
Seropositivity of the different age groups of cattle to Mycoplasma bovis 
Antibodies to M. bovis 
Positive Negative Age Number of animals 
Number % Number % 
Average 
ODC% 
< 90 days 26 15 57.69 11 42.31 18.28a 
91–180 days 678 552 81.42 126 18.58 28.26b 
181–270 days 113 106 93.81 7 6.19 34.38c 
271–365 days 10 10 100 0 0 37.08bcd 
> 365 days 22 20 90.91 2 9.09 28.33abcd 
No data on age 11 10 90.91 1 9.09 n. d. 
Total 860 713 82.91 147 17.09 n. d. 
Means within the column with different superscripts differ (P < 0.05); n. d.: not done; ODC: optical 
density coefficient 
 
The high rate of M. bovis infection in the cattle herds examined was rather 
surprising. A similar evaluation detected 11.3% seropositivity in Hungary when 
examining 595 animals in 34 cattle herds using a different type of ELISA; how-
ever in some herds the rate of the seropositivity reached 57.2% (Tenk et al., 
2004). According to our data the proportion of seropositive herds increased from 
64.7% to 100%. The majority of animals were weakly positive, which can be due 
to asymptomatic colonisation of the respiratory mucous membranes by M. bovis. 
The elevated rate of infection may result from the increased trade of cattle in the 
recent decade as it is seen in several other countries. According to a survey in It-
aly, 76% of beef and 100% of veal calves were seropositive to M. bovis (Radaelli 
et al., 2008). A high infection rate was found at a Lithuanian cattle breeding sta-
tion, where 75% of 110 day-old calves were seropositive (Gabinaitiene et al., 
2011). In 8 out of 9 French feedlots 60 to 100% of the animals had seroconverted 
(Arcangioli et al., 2008). Mycoplasma bovis was detected more frequently from 
 SEROPOSITIVITY TO MYCOPLASMA BOVIS 171 
Acta Veterinaria Hungarica 65, 2017 
pneumonic calves (Gagea et al., 2006a; Soehnlen et al., 2012). The proportion of 
seropositive animals increased with age and a significant difference was seen in 
the level of seropositivity between young and older animals.  
The high infection rate of Hungarian cattle herds with M. bovis shows that 
special attention should be paid to evaluating the aetiological role of M. bovis in 
BRDC cases. The pathogenic impact of M. bovis is highly underestimated. As a 
primary pathogen it can cause various diseases in cattle and due to its immuno-
suppressive nature it can predispose cattle to other respiratory diseases. The iden-
tification of M. bovis infection is a precondition of the effective treatment, pre-
vention and control of BRDC. 
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